Marshall Wace, LLP Tilray Brands, Inc. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.58 - $4.68 $6.32 Million - $11.5 Million	2,448,494 New	2,448,494 $6.59 Million
Q2 2022 Aug 15, 2022	BUY	$3.11 - $7.48 $10,788 - $25,948	3,469 Added 10.93%	35,200 $110,000
Q2 2021 Aug 13, 2021	SELL	$13.68 - $22.34 $7.53 Million - $12.3 Million	-550,524 Reduced 94.55%	31,731 $574,000
Q1 2021 May 17, 2021	BUY	$9.0 - $63.91 $5.24 Million - $37.2 Million	582,255 New	582,255 $13.2 Million
Q1 2020 May 15, 2020	SELL	$2.47 - $21.36 $3,332 - $28,814	-1,349 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$15.72 - $24.88 $16,977 - $26,870	-1,080 Reduced 44.46%	1,349 $23,000
Q3 2019 Nov 14, 2019	BUY	$24.74 - $49.3 $60,093 - $119,749	2,429 New	2,429 $60,000

405

99.8M

8.6M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $874M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.